美國(guó)Seracare衣原體IgG（Chlamydia IgG）

廣州健侖生物科技有限公司

廣州健侖長(zhǎng)期供應(yīng)各種生物原料，主要代理品牌：美國(guó)Seracare、西班牙Certest、美國(guó)Fuller等等。

主要產(chǎn)品包括各種標(biāo)準(zhǔn)品、陽(yáng)性對(duì)照品、單克隆抗原抗體。

其中常見(jiàn)的有：弓形蟲病、西尼羅河病毒、類風(fēng)濕因子、瘧疾、麻疹、萊姆病、百日咳桿菌、大腸桿菌、鼠傷寒沙門氏菌、李斯特菌等陽(yáng)性對(duì)照品。

美國(guó)Seracare衣原體IgG（Chlamydia IgG）

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢2042552662

【Seracare產(chǎn)品介紹】

編號(hào)

英文名稱

中文名稱

JL-FA-01

Amebiasis (AME)

阿米巴病

JL-FA-02

Allergens, Rast scores

過(guò)敏原，放射性過(guò)敏原吸收實(shí)驗(yàn)。指對(duì)特定的人群引起免疫反應(yīng)或者過(guò)敏反應(yīng)的食品中的蛋白質(zhì)

JL-FA-03

Allergens, Rast scores negative

過(guò)敏原，放射性過(guò)敏原吸收實(shí)驗(yàn)陰性

JL-FA-04

Anti-cyclic citrullinated peptide Antibody (CCP) Arthritis

抗環(huán)瓜氨酸肽抗體

JL-FA-05

ASCA Saccharomyces Cerevi

人抗釀酒酵母抗體（ASCA）

JL-FA-06

Aspergillis

麴菌病

JL-FA-07

Beta 2 Glycoprotein

2糖蛋白

JL-FA-08

Beta 2 Glycoprotein  IgM

2糖蛋白 IGM

JL-FA-09

Bordela Pertussis

百日咳桿菌

JL-FA-10

Bordela Pertussis IgM

百日咳桿菌 IGM

JL-FA-11

C-ANCA

C-抗中性粒細(xì)胞胞漿抗體（ANCA)

JL-FA-12

Cardiolipin

心肌磷脂

JL-FA-13

Cardiolipin IgA

心肌磷脂 IGA

JL-FA-14

Cardiolipin IgG

心肌磷脂 IGG

JL-FA-15

Cardiolipin IgM

心肌磷脂 IGM

JL-FA-16

Cerebral Spinal Fluid

腦脊髓液

JL-FA-17

Chagas

恰加斯病/南美錐蟲

JL-FA-18

Chlamydia

衣原體

JL-FA-19

Chlamydia IgA

衣原體IGA

JL-FA-20

Chlamydia IgG

衣原體IGG

JL-FA-21

Chlamydia IgM

衣原體IGM

JL-FA-22

Chlamydia Neg

衣原體陰性

JL-FA-23

Clotting Factor C3

凝固因子C3

JL-FA-24

Clotting Factor C4

凝固因子C4

JL-FA-25

Coccidiodes

球孢菌

JL-FA-26

Cytomegalovirus (CMV) Neg

巨細(xì)胞病毒抗體陰性

JL-FA-27

CMV IgG

巨細(xì)胞病毒 IGG陽(yáng)性

JL-FA-28

CMV IgM VCA

巨細(xì)胞病毒 IGM 陽(yáng)性

JL-FA-29

C-Reactive Protein (CRP)

C-反應(yīng)蛋白質(zhì)

JL-FA-30

Dengue Fever

登革熱

JL-FA-31

Dengue Fever IgM

登革熱 IGM

JL-FA-32

DS (Double Stranded) DNA

雙鏈脫氧核糖核酸

JL-FA-33

EBNA (Epstein-Barr nuclear antigen) IgG

EB病毒核抗原 IGG

JL-FA-34

EBNA (Epstein-Barr nuclear antigen) IgM

EB病毒核抗原 IGM

JL-FA-35

Epstein Barr Virus (EBV) Negative Plasma

EB病毒陰性血漿

JL-FA-36

Epstein Barr Virus (EBV) EA IgM

EB病毒早期抗原 IGM

JL-FA-37

Epstein Barr Virus (EBV) VCA IgM

EB病毒殼蛋白 IGM

JL-FA-38

Epstein Barr Virus (EBV) EA IgG

EB病毒早期抗原 IGG

JL-FA-39

EMA (Endomysial Antibodies)

肌內(nèi)膜

JL-FA-40

Gliadin

麩蛋白,麥醇溶蛋白,麥膠蛋白

JL-FA-41

Gliadin IgG

麥醇溶蛋白 IGG

JL-FA-42

Gliadin IgA

麥醇溶蛋白 IGA

JL-FA-43

Glomerular Basement Membrane (GBMA)

腎小球基底膜病

JL-FA-44

Helicobacter pylori IgA

幽門螺旋桿菌IGA

JL-FA-45

Helicobacter pylori IgG

幽門螺旋桿菌IGG

JL-FA-46

Helicobacter pylori IgM

幽門螺旋桿菌IGM

JL-FA-47

Helicobacter pylori Negative

幽門螺旋桿菌陰性

JL-FA-48

Helicobacter pylori Positive Plasma

幽門螺旋桿菌陰性血漿

JL-FA-49

Hepatitis A Virus (HAV) Pos. Plasma

甲型肝炎病毒陽(yáng)性血漿

JL-FA-50

Hepatitis A Virus (HAV) IgM

甲型肝炎病毒IGM

JL-FA-51

Hepatitis B Core (HBc) IgG

乙型肝炎病毒核心 IGG

JL-FA-52

Hepatitis B Core (HBc) IgM

乙型肝炎病毒核心 IGM

JL-FA-53

Anti Hbe (Antibody to HBV antigen)

乙肝抗體

JL-FA-54

Hepatitis Delta Virus

丁型肝炎病毒

JL-FA-55

HBeAg (HBV e antigen)

乙肝 E抗原

JL-FA-56

anti-HBs (HBV surface antibody)

乙肝表面抗體

JL-FA-57

Hepatitis B (HBsAg) "Chronic"

乙型肝炎（乙肝表面抗原） 慢性病

JL-FA-58

HBsAg (HBV surface antigen) Serum

乙肝表面抗原血清

JL-FA-59

HBsAg (AD)

乙肝表面抗原（AD）

JL-FA-60

HBsAg (AY)

乙肝表面抗原（AY）

JL-FA-61

HBV Positive Plasma

乙肝陽(yáng)性血漿

JL-FA-62

HBV DNA Plasma

乙肝DNA血漿

JL-FA-63

HBV DNA Serum

乙肝DNA血清

JL-FA-64

HBV DNA type A

 A型 乙肝DNA

JL-FA-65

HBV DNA type B

 B型 乙肝DNA

JL-FA-66

HBV DNA type C

 C型 乙肝DNA

JL-FA-67

HBV DNA type D

 D型 乙肝DNA

JL-FA-68

HBV DNA type E

 E型 乙肝DNA

JL-FA-69

HBV DNA type F

 F型 乙肝DNA

JL-FA-70

HBV Antibody HCV Antibody Plasma CO-INFECTED

乙肝和丙肝聯(lián)合感染血漿

JL-FA-71

HCV (Hepatitis C Virus) Antibody

丙型肝炎抗體

JL-FA-72

HCV Core Antigen Positive

丙肝核心抗原 陽(yáng)性

JL-FA-73

HCV RNA PLASMA Genotype 1

基因1型丙肝RNA 血漿

JL-FA-74

HCV RNA PLASMA Genotype 2

基因2型丙肝RNA 血漿

JL-FA-75

HCV RNA PLASMA Genotype 3

基因3型丙肝RNA 血漿

JL-FA-76

HCV RNA PLASMA Genotype 4

基因4型丙肝RNA 血漿

JL-FA-77

HCV RNA PLASMA Genotype 5

基因5型丙肝RNA 血漿

JL-FA-78

HCV RNA PLASMA Genotype 6

基因6型丙肝RNA 血漿

JL-FA-79

HCV Riba single band

丙肝免疫印跡單波段

JL-FA-80

HCV RIBA Pos. (multiple bands)

丙肝免疫印跡陽(yáng)性多波段

JL-FA-81

HCV Negative

丙肝陰性

JL-FA-82

HCV RNA Pos (quantitative)

丙肝RNA陽(yáng)性（定量）

JL-FA-83

Hepatitis E

戊型肝炎

JL-FA-84

Herpes Simplex Virus (HSV)1/2 Positive Plasma

單純性皰疹病毒1/2陽(yáng)性血漿

JL-FA-85

Herpes Simplex Virus (HSV) 1 Negative Plasma

單純性皰疹病毒1 陰性血漿

JL-FA-86

Herpes Simplex Virus (HSV) 1 IgG

單純性皰疹病毒1 IGG

JL-FA-87

Herpes Simplex Virus (HSV 1) IgM

單純性皰疹病毒1 IGM

JL-FA-88

Herpes Simplex Virus (HSV) 2 IgG

單純性皰疹病毒2 IGG

JL-FA-89

Herpes Simplex Virus (HSV) 2 IgM

單純性皰疹病毒2 IGG

JL-FA-90

Histone

組蛋白

JL-FA-91

Human Anti Mouse Ab (HAMA)

人抗鼠抗體

JL-FA-92

Human immunodeficiency virus (HIV) 1 Neg

HIV  I 陰性

JL-FA-93

anti Human immunodeficiency virus (HIV) 1 Plasma

抗HIV  I 血漿

JL-FA-94

anti Human immunodeficiency virus (HIV) 1 Serum

抗HIV  I 血清

JL-FA-95

anti Human immunodeficiency virus (HIV) 2 Western Blot Tested

抗HIV  2 免疫印跡

JL-FA-96

anti Human immunodeficiency virus (HIV) 1/2 2 HIV (+)

抗HIV 1/2 2  HIV陽(yáng)性

JL-FA-97

Human immunodeficiency virus (HIV) Ag

HIV抗原

JL-FA-98

HIV RNA (quantitative) Plasma

HIV RNA 定量血漿

JL-FA-99

HIV RNA (quantitative) Serum

HIV RNA 定量血清

JL-FA-100

HIV1 Subtype A

HIV1  亞型A

JL-FA-101

HIV1 Subtype B

HIV1  亞型B

JL-FA-102

HIV1 Subtype C

HIV1  亞型C

JL-FA-103

HIV1 Subtype D

HIV1  亞型D

JL-FA-104

HIV1 Subtype E

HIV1  亞型E

JL-FA-105

HIV1 Subtype F

HIV1  亞型F

JL-FA-106

HIV1 Subtype G

HIV1  亞型G

JL-FA-107

HIV1 Subtype H

HIV1  亞型H

JL-FA-108

HIV1 Subtype J

HIV1  亞型J

JL-FA-109

HIV1 Subtype K

HIV1  亞型K

JL-FA-110

HIV1 Group O

HIV1  亞型O

JL-FA-111

Human immunodeficiency virus (HIV) 2 Antibody Plasma

HIV 2 抗體血漿

JL-FA-112

Human immunodeficiency virus (HIV) 2 Antibody Serum

HIV 2 抗體血清

JL-FA-113

HPV (Human Papiloma Virus) Negative

人乳狀瘤病毒HPV陰性

JL-FA-114

HPV (Human Papiloma Virus) Positive

人乳狀瘤病毒HPV陽(yáng)性

JL-FA-115

Human immunodeficiency virus (HIV) Antibody HCV Antibody Plasma COINFECTED

HIV 抗體 HCV

JL-FA-116

Human T-cell Lymphotropic Virus (HTLV) I/II

人嗜T淋巴細(xì)胞病毒(HTLV) I/II

JL-FA-117

Human T-cell Lymphotropic Virus (HTLV) I

人嗜T淋巴細(xì)胞病毒(HTLV) I

JL-FA-118

Human T-cell Lymphotropic Virus (HTLV) II

人嗜T淋巴細(xì)胞病毒(HTLV) II

JL-FA-119

Jo-1

多發(fā)性肌炎抗原JO-1

JL-FA-120

IgE 5,000 Ku/L

IgE 5,000 Ku/L

JL-FA-121

Legionella

軍團(tuán)桿菌屬

JL-FA-122

Leptospira

軍團(tuán)桿菌屬

JL-FA-123

Lyme Disease

萊姆(氏)病:蜱傳播的全身性疾病,常在夏季發(fā)生

JL-FA-124

Lyme IgG

萊姆(氏)病 IGG

JL-FA-125

Lyme IgM

萊姆(氏)病 IGM

JL-FA-126

Lyme Disease Neg

萊姆(氏)病 陰性

JL-FA-127

Malaria

瘧疾

JL-FA-128

Mononucleosis (infectious)

單核細(xì)胞增多癥（有傳染性的）

JL-FA-129

Mononucleosis Negative

單核細(xì)胞增多癥陰性

JL-FA-130

Measles Negative

麻疹 陰性

JL-FA-131

Measles IgG

麻疹 IGG

JL-FA-132

Measles IgM

麻疹 IGM

JL-FA-133

Microsomal Anti-thyroid peroxidase antibody (TPO) Positive Plasma Standard Titer (typically 1,000-3,000 IU/mL)

微粒體抗甲狀腺過(guò)氧化物酶抗體

JL-FA-134

Microsomal Anti-thyroid peroxidase antibody (TPO) Negative Plasma

微粒體抗甲狀腺過(guò)氧化物酶抗體

JL-FA-135

Anti-mitochondrial antibody (AMA)

抗線粒體抗體

JL-FA-136

Multiple Sclerosis

多發(fā)性硬化癥

JL-FA-137

Mumps IgG

流行性腮腺炎 IGG

JL-FA-138

Mumps Ab IgM

流行性腮腺炎抗體 IGM

JL-FA-139

Mumps Antibody Negative Plasma

流行性腮腺炎抗體陰性血漿

JL-FA-140

Mumps Antibody Negative Serum

流行性腮腺炎抗體陰性血清

JL-FA-141

Myeloma Plasma

骨髓瘤血漿

JL-FA-142

Myeloma IgA

骨髓瘤IGA

JL-FA-143

Myeloma IgE

骨髓瘤IGE

JL-FA-144

Myeloma IgG

骨髓瘤IGG

JL-FA-145

Myeloma IgM

骨髓瘤IGM

JL-FA-146

Mycoplasma

支原體

JL-FA-147

Mycoplasma Negative

支原體陰性

JL-FA-148

Mycoplasma IgG

支原體IGG

JL-FA-149

Mycoplasma IgM

支原體IGM

JL-FA-150

Mycoplasma PCR

支原體PCR

JL-FA-151

Normal Human Plasma

正常人血漿

JL-FA-152

Normal Human Serum

正常人血清

JL-FA-153

Nuclear Antibody Centromere

核抗體著絲粒

JL-FA-154

Nuclear Antibody, Speckled ANA

核抗體，斑點(diǎn)抗核抗體

JL-FA-155

Nuclear Antibody, Nucleolar ANA

核抗體,核仁抗核抗體

JL-FA-156

Nuclear Antibody, Homogeneous ANA

核抗體，同質(zhì)抗核抗體

JL-FA-157

Nuclear Antiobody, Speckled. (ANA) Negative

核抗體，斑點(diǎn)。抗核抗體陰性

JL-FA-158

P-ANCA (associated neutrophil cytoplasmic antibodies)

相關(guān)的嗜中性粒細(xì)胞胞漿抗體

JL-FA-159

Parietal Cell Antibody (PCA)

胃)壁細(xì)胞抗體

JL-FA-160

Parvo positive plasma

細(xì)小病毒陽(yáng)性血漿

JL-FA-161

Parvo IgM

細(xì)小病毒 IGM

JL-FA-162

Parvo IgG

細(xì)小病毒 IGG

JL-FA-163

Parvo Negative Plasma

細(xì)小病毒陰性血漿

JL-FA-164

Parvo DNA positive

細(xì)小病毒 DNA 陽(yáng)性

JL-FA-165

Phospholipid Positive Plasma

磷脂陽(yáng)性血漿

JL-FA-166

Prothrombin

凝血酶原,凝血因子

JL-FA-167

Rheumatoid Factor (RF) 1000 IU/mL

類風(fēng)濕因子 1000 IU/mL

JL-FA-168

Rheumatoid Factor (RF) 1001-2000 IU/mL

類風(fēng)濕因子1001-2000 IU/mL

JL-FA-169

Rheumatoid Factor (RF) 2001-4000 IU/mL

類風(fēng)濕因子 2001-4000 IU/mL

JL-FA-170

Rheumatoid Factor (RF) 4001-5000 IU/mL

類風(fēng)濕因子 4001-5000 IU/mL

JL-FA-171

Rheumatoid Factor (RF) 5000 IU/mL

類風(fēng)濕因子 5000 IU/mL

JL-FA-172

Ribonucleoprotein (RNP) Positive

核糖核蛋白陽(yáng)性

JL-FA-173

Rubella Chimeric

風(fēng)疹

JL-FA-174

Rubella Negative

風(fēng)疹陰性

JL-FA-175

Rubella IgG

風(fēng)疹I(lǐng)GG

JL-FA-176

Rubella IgM

風(fēng)疹I(lǐng)GM

JL-FA-177

Rubeola Negative Plasma

風(fēng)疹陰性血漿

JL-FA-178

Rubeola IgG

風(fēng)疹I(lǐng)GG

JL-FA-179

Scleroderma (Scl-70) Pos

膠原沉著病,硬皮病,硬皮癥 陽(yáng)性

JL-FA-180

Scleroderma (Scl-70) Negative

硬皮病陰性

JL-FA-181

Sickle Cell Fresh Whole Blood

鐮刀形紅細(xì)胞新鮮全血

JL-FA-182

Smith (SM)

抗Smith抗體陽(yáng)性血清（SLE的特征性抗體）

JL-FA-183

SMITH RNP

抗RNP抗體陽(yáng)性血清（SLE的特征性抗體）

JL-FA-184

Smooth Muscle (ASMA)

抗平滑肌抗體陽(yáng)性血清

JL-FA-185

Sjogren syndrome antigen A (SSA) Positive

舍格倫綜合征或干燥綜合征抗原A 陽(yáng)性

JL-FA-186

Sjogren syndrome antigen B (SSB) Positive

舍格倫綜合征抗原B 陽(yáng)性

JL-FA-187

Sjogren syndrome antigen B (SSB) Negative

舍格倫綜合征抗原B陰性

JL-FA-188

Streptolysin O Ab (ASO)

鏈球菌溶血素O抗體

JL-FA-189

Syphilis (RPR - Rapid Plasma Reagin) Positive Plasma

梅毒（梅毒-快速血漿反應(yīng)）陽(yáng)性血漿

JL-FA-190

Syphilis (RPR - Rapid Plasma Reagin) Negative Plasma

梅毒（梅毒-快速血漿反應(yīng)）陰性血漿

JL-FA-191

Syphilis/ATA/T. pallidum IgG

梅毒ATA/T，蒼白球IGG

JL-FA-192

Syphilis/ATA/T. pallidum IgM

梅毒ATA/T，蒼白球IGM

JL-FA-193

Systemic Lupus Erythematosus (SLE) Positive

全身性紅斑狼瘡陽(yáng)性

JL-FA-194

Systemic Lupus Erythematosus (SLE) Negative

全身性紅斑狼瘡陰性

JL-FA-195

TG/TPO Positive (Standard Titer 1,000 - 3000 IU/mL)

甲狀腺球蛋白/甲狀腺過(guò)氧化物酶陽(yáng)性

JL-FA-196

TG/TPO Negative

甲狀腺球蛋白/甲狀腺過(guò)氧化物酶陰性

JL-FA-197

TTG (Tissue Transglutaminase)

組織轉(zhuǎn)谷氨酰胺酶

JL-FA-198

TTG (Tissue Transglutaminase) IgA

組織轉(zhuǎn)谷氨酰胺酶 IGA

JL-FA-199

ToRCH (Toxo, Rubella, CMV, HSV) Positive

優(yōu)生優(yōu)育（弓形蟲，風(fēng)疹，巨細(xì)胞，單胞）陽(yáng)性

JL-FA-200

ToRCH (Toxo, Rubella, CMV, HSV) Negative

優(yōu)生優(yōu)育（弓形蟲，風(fēng)疹，巨細(xì)胞，單胞）陰性

JL-FA-201

Toxoplasmosis (Toxo)

弓形蟲病

JL-FA-202

Toxoplasmosis (Toxo) IgG

弓形蟲病IGG

JL-FA-203

Toxoplasmosis (Toxo) IgM

弓形蟲病IGM

JL-FA-204

Thyroglobulin (TG) Positive Plasma

甲狀腺球蛋白陽(yáng)性血漿

JL-FA-205

Thyroglobulin (TG) Negative

甲狀腺球蛋白陰性

JL-FA-206

Varicella-Zoster Virus (VZV) Negative

水痘-帶狀皰疹病毒陰性

JL-FA-207

Varicella-Zoster Virus (VZV) IgG

水痘-帶狀皰疹病毒IGG

JL-FA-208

Varicella-Zoster Virus (VZV) IgM

水痘-帶狀皰疹病毒IGM

JL-FA-209

West Nile Virus (WNV)

西尼羅河腦炎病毒

JL-FA-210

West Nile Virus (WNV) IgM

西尼羅河腦炎病毒IGM

美國(guó)Seracare衣原體IgG（Chlamydia IgG）

美國(guó)斯隆-凱特琳研究所等處的研究人員創(chuàng)建了一種多能干細(xì)胞基因組編輯平臺(tái)：iCRISPR，這一平臺(tái)能快速，高效的敲除干細(xì)胞中的基因，而且還能在干細(xì)胞分化過(guò)程中，進(jìn)行階段特異性的基因敲除，這將在人類疾病復(fù)雜病理研究中大放異彩。相關(guān)文章發(fā)表于2014年6月12日的《Cell Stem Cell》雜志上。
人體多能干細(xì)胞(hPSCs)不僅能被用于臨床的再生研究應(yīng)用中，而且也能作為解析復(fù)雜性狀和特征的獨(dú)特平臺(tái)，闡明其背后的基因和分子途徑。為了實(shí)現(xiàn)這一目的，科學(xué)家們開(kāi)發(fā)了多種遺傳操控方法，但是這些方法依然存在各種問(wèn)題，我們需要快速，具有可操控性的生物學(xué)手段。
在這篇文章中，研究人員就利用CRISPR和TALEN，這兩種備受關(guān)注的基因組編輯技術(shù)，研發(fā)出了一種人類多能干細(xì)胞基因組編輯平臺(tái)。研究人員將這一平臺(tái)稱為iCRISPR。
iCRISPR能用于基因功能喪失研究中，快速，高效的敲除人體多能干細(xì)胞中的等位基因，也可以針對(duì)一些精確的疾病模型，通過(guò)特定的核苷酸變換，進(jìn)行多能干細(xì)胞純合體敲除。
通過(guò)進(jìn)一步實(shí)驗(yàn)，研究人員驗(yàn)證了雙重和三重基因敲除hPSC細(xì)胞系一步法的有效性，同時(shí)也證明了在多能干細(xì)胞分化過(guò)程中能進(jìn)行階段特異性誘導(dǎo)基因敲除，這對(duì)于發(fā)育生物學(xué)研究來(lái)說(shuō)意義重大。
由此研究人員指出，iCRISPR平臺(tái)尤其適合用于解析人類疾病研究中的復(fù)雜遺傳相互作用，以及多效性基因功能，這將有助于進(jìn)行人體多能干細(xì)胞高通量遺傳分析。
除了這項(xiàng)研究之外，去年來(lái)自加州大學(xué)舊金山分校的研究人員提出了一個(gè)相似的名稱：CRISPRi，他們發(fā)現(xiàn)當(dāng)缺失核酸內(nèi)切酶活性的Cas9與一種導(dǎo)向RNA共表達(dá)時(shí)候，會(huì)產(chǎn)生一種DNA識(shí)別復(fù)合物，這種復(fù)合物能特異性干擾轉(zhuǎn)錄延伸，RNA聚合酶結(jié)合，或轉(zhuǎn)錄因子結(jié)合。
由此研究人員研發(fā)出了這種CRISPRi系統(tǒng)，這一系統(tǒng)能有效抑制大腸桿菌中靶向基因的表達(dá)，并且不會(huì)出現(xiàn)脫靶效應(yīng)。而且利用CRISPRi，還可以同時(shí)抑制多個(gè)靶基因，這種作用也是可逆。研究人員還證明，該系統(tǒng)也適用于哺乳動(dòng)物細(xì)胞中的基因表達(dá)抑制。
加州大學(xué)圣迭戈分校(University of California, San Diego)醫(yī)學(xué)院研究人員針對(duì)自閉癥研究出一套比較新銳的理論，并對(duì)其進(jìn)行了實(shí)際測(cè)試。研究結(jié)果顯示，自閉癥實(shí)際上是由異常的細(xì)胞通訊導(dǎo)致的，使用問(wèn)世已逾百年的治療嗜睡癥的藥物，可以恢復(fù)患有自閉癥的老鼠體內(nèi)的細(xì)胞活動(dòng)，消除老鼠的神經(jīng)失調(diào)癥狀。參與實(shí)驗(yàn)的老鼠年齡相當(dāng)于人類30歲左右。相關(guān)研究成果在2014年6月17日的在線刊物《平移精神病學(xué)(Translational Psychiatry)》中發(fā)表。

美國(guó)Seracare衣原體IgA（Chlamydia IgA）

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】   楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

Researchers at the U.S.-based Sloan-Caitlin Institute have created iCRISPR, a pluripotent stem cell genomics editing platform that rapidly and efficiently knocks out genes in stem cells and helps them differentiate stem cells during stem cell differentiation, Performing stage-specific knockouts will shine in the complex pathology of human disease. The article appeared in the June 12, 2014 issue of Cell Stem Cell.
Not only can human pluripotent stem cells (hPSCs) be used in clinical regenerative research applications, but also as a unique platform for analyzing complex traits and traits, elucidating the underlying genetic and molecular pathways. To achieve this goal, scientists have developed a variety of genetic manipulation methods, but there are still a variety of problems with these methods, and we need fast, manipulative biological tools.
In this article, researchers developed a human pluripotent stem cell genome editing platform using two well-regarded genome editing technologies, CRISPR and TALEN. The researchers call this platform iCRISPR.
iCRISPR can be used in gene loss studies to rapidly and efficiently knock out alleles in pluripotent human pluripotent stem cells and to target specific models of disease through specific nucleotide transforms for pluripotent stem cell homozygous knocking except.
Through further experiments, the researchers validated the one-step efficacy of double and triple knockout hPSC cell lines, and also demonstrated that stage-specific induction of gene knockdown during pluripotent stem cell differentiation can be performed in developmental biology Meaningful.
As a result, the researchers noted that the iCRISPR platform is particularly well-suited for the analysis of complex genetic interactions in human disease research and pleiotropic gene functions that will facilitate high-throughput genetic analysis of human pluripotent stem cells.
In addition to the study, researchers from the University of California, San Francisco, last year proposed a similar name: CRISPRi, who found that a DNA lacking endonuclease co-expressed with a directing RNA produced a DNA Recognition complexes that specifically interfere with transcriptional elongation, RNA polymerase binding, or transcription factor binding.
As a result, the researchers developed the CRISPRi system, which effectively inhibits the expression of the targeted genes in E. coli and does not show off-target effects. And using CRISPRi, you can also inhibit multiple target genes, this effect is also reversible. The researchers also demonstrated that the system is also suitable for gene expression inhibition in mammalian cells.
Researchers at the University of California, San Diego Medical School developed a set of cutting-edge theories of autism and conducted practical tests. The results show that autism is actually caused by abnormal cell communication, the use of more than a century has come out of the treatment of narcolepsy drugs, can restore autism in mice with cell activity in vivo, to eliminate symptoms of neurological disorders in mice . The age of the mice involved in the experiment is about 30 years old. Relevant research results are published in the June 17, 2014 online translation "Translational Psychiatry."